World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
9997
World Ranking
4199
National Ranking
97

Mark E. Jones publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mark E. Jones sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 128 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mark E. Jones D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark E. Jones sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 52 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mark E. Jones is affiliated with Basilea Pharmaceutica in Switzerland. Their research spans multiple domains within biochemistry, genetics, and molecular biology, with a particular emphasis on genomics and phylogenetic studies. Their work addresses key topics such as genetic diversity and population structure, bioinformatics and genomic networks, and genome rearrangement algorithms.

The scientist has produced a substantial body of work that contributes to both theoretical and applied aspects of molecular biology and genetics. The following topics characterize their primary research interests:

  • Genomics and Phylogenetic Studies
  • Genetic diversity and population structure
  • Bioinformatics and Genomic Networks
  • Evolution and Paleontology Studies
  • Genome Rearrangement Algorithms
  • Plant and animal studies
  • Algorithms and Data Compression

Jones has collaborated frequently with several researchers, highlighting active partnerships in their scientific pursuits. Frequent co-authors include:

  • Leo van Iersel
  • Yukihiro Murakami
  • Remie Janssen
  • Norbert Zeh
  • Katharina T. Huber

Their academic output has appeared in various publication venues, including:

  • arXiv (Cornell University)
  • Algorithmica
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Computer and System Sciences
  • SSRN Electronic Journal

Recent significant publications by Mark E. Jones include:

  • "Distinguishing level-1 phylogenetic networks on the basis of data generated by Markov processes," 2021, Journal of Mathematical Biology
  • "Orchard Networks are Trees with Additional Horizontal Arcs," 2022, Bulletin of Mathematical Biology
  • "A Practical Fixed-Parameter Algorithm for Constructing Tree-Child Networks from Multiple Binary Trees," 2022, Algorithmica
  • "A unifying characterization of tree-based networks and orchard networks using cherry covers," 2021, Data Archiving and Networked Services (DANS)
  • "Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia," 2023, Antibiotics

The integration of computational methods and biological principles features prominently within Jones's work, intersecting with subfields such as molecular biology, genetics, paleontology, ecology, evolution, behavior, systematics, and artificial intelligence. This cross-disciplinary range supports advancements in understanding evolutionary patterns, genetic networks, and algorithmic approaches to biological data.

Best Publications

  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States

    James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones

  • Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

    James A. Karlowsky;Deborah C. Draghi;Mark E. Jones;Clyde Thornsberry

  • Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.

    Ad C. Fluit;Mark E. Jones;Franz-Josef Schmitz;Jacques Acar

  • Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

    Clyde Thornsberry;Mark E. Jones;Mary L. Hickey;Yolanda Mauriz

  • Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

    Daniel F. Sahm;Clyde Thornsberry;David C. Mayfield;Mark E. Jones

  • Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)

    Mark E Jones;Deborah C Draghi;Clyde Thornsberry;James A Karlowsky

  • Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.

    P. Martinez-Freijo;A. C. Fluit;F.-J. Schmitz;V. S. C. Grek

  • Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000

    Clyde Thornsberry;Daniel F. Sahm;Laurie J. Kelly;Ian A. Critchley

  • Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

    Mark E. Jones;James A. Karlowsky;Deborah C. Draghi;Clyde Thornsberry

  • The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.

    Franz-Josef Schmitz;Ad C. Fluit;Mechthild Gondolf;Ralf Beyrau

  • Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

    James A Karlowsky;Mark E Jones;Deborah C Draghi;Clyde Thornsberry

  • Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998–2002)

    James A. Karlowsky;Clyde Thornsberry;Mark E. Jones;Alan T. Evangelista

  • The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.

    Franz-Josef Schmitz;Ad C. Fluit;Marc Lückefahr;Beate Engler

  • Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season

    Mark E. Jones;Daniel F. Sahm;Nele Martin;Sibylle Scheuring

  • Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001

    James A. Karlowsky;Mark E. Jones;Clyde Thornsberry;Ian R. Friedland

  • Characterization of grlA,grlB, gyrA, and gyrB Mutations in 116 Unrelated Isolates of Staphylococcus aureus and Effects of Mutations on Ciprofloxacin MIC

    Franz-Josef Schmitz;Mark E. Jones;Basia Hofmann;Birgit Hansen

  • Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002.

    Robert K. Flamm;Mellany K. Weaver;Clyde Thornsberry;Mark E. Jones

  • Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis

    Daniel F. Sahm;James A. Karlowsky;Laurie J. Kelly;Ian A. Critchley

  • Emergence and Spread in French Hospitals of Methicillin-Resistant Staphylococcus aureus with Increasing Susceptibility to Gentamicin and Other Antibiotics

    Hervé Lelièvre;Gerard Lina;Mark E. Jones;Claude Olive

  • Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000–2001

    Ian A Critchley;Deborah C Draghi;Daniel F Sahm;Clyde Thornsberry

  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the

    James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones

  • Original articles Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds

    P. Martinez-Freijo;A. C. Fluit;V. S. C. Grek;J. Verhoef

Frequent Co-Authors

Clyde Thornsberry
Clyde Thornsberry Centers for Disease Control and Prevention
James A. Karlowsky
James A. Karlowsky University of Manitoba
Ian A. Critchley
Ian A. Critchley Spero Therapeutics (United States)
Ad C. Fluit
Ad C. Fluit Utrecht University
Helio S. Sader
Helio S. Sader JMI Laboratories
Jan Verhoef
Jan Verhoef Utrecht University
François Vandenesch
François Vandenesch Claude Bernard University Lyon 1
Jerome Etienne
Jerome Etienne Claude Bernard University Lyon 1
James O. Kahn
James O. Kahn Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors to various career paths, many of which intersect with health sciences and technology fields. For example, professionals interested in patient-centered care might explore programs like functional medicine np programs, which blend traditional nursing expertise with holistic health approaches.

Alternatively, those drawn to the administrative side of healthcare may consider roles in health information management. This growing field offers promising opportunities, detailed in the health information management job description and salary insights, showcasing its importance in managing patient data and improving healthcare delivery.

To get started, students should seek accredited online health information management degree cahiim programs that meet industry standards and prepare graduates for certification.

Moreover, the role of coding within healthcare is critical for accurate billing and records. Exploring the certified professional coder salary landscape can provide insight into the financial and professional benefits of this career path.

Best Scientists Citing Mark E. Jones

Trending Scientists

Recently Published Articles